Low prevalence of human papillomavirus in head and neck squamous cell carcinoma in Chinese patients

Journal of Medical Virology

Volumn 87, Issue 2, 2015, Pages 281-286

  Xu, Yanan ^a,b,c   Liu, Suru ^a,c   Yi, Hongliang ^a,c   Wang, Jiadong ^b,c   Luo, Yanli ^a   Yin, Shankai ^a,c  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Head and neck squamous cell carcinoma; Human papillomavirus; Prevalence; Prognosis; Survival

Indexed keywords

CISPLATIN; DOCETAXEL; PROTEIN P16;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CHINESE; FEMALE; GENOTYPE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 33; IMMUNOHISTOCHEMISTRY; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CANCER; OVERALL SURVIVAL; PREVALENCE; SMOKING; WART VIRUS; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; CHINA; CLASSIFICATION; GENETICS; HEAD AND NECK NEOPLASMS; ISOLATION AND PURIFICATION; MIDDLE AGED; MOLECULAR DIAGNOSIS; PAPILLOMAVIRIDAE; SURVIVAL; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; CHINA; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PREVALENCE; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84919675630     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24052     Document Type: Article

References (24)

1. Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, Zhang N, El-Naggar AK, Jasser SA, Weinstein JN, Trevino L, Drummond JA, Muzny DM, Wu Y, Wood LD, Hruban RH, Westra WH, Koch WM, Califano JA, Gibbs RA, Sidransky D, Vogelstein B, Velculescu VE, Papadopoulos N, Wheeler DA, Kinzler KW, Myers JN. 2011. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333:1154-1157.
2. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. Group WHOIAfRoCMW. 2009. A review of human carcinogens-Part B: Biological agents. Lancet Oncol 10:321-322.
3. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML. 2007. Case-control study of human papillomavirus and oropharyngeal cancer. New Engl J Med 356:1944-1956.
4. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, Viscidi R. 2008. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer I 100:407-420.
5. Guihard S, Ramolu L, Macabre C, Wasylyk B, Noel G, Abecassis J, Jung AC. 2012. The NEDD8 conjugation pathway regulates p53 transcriptional activity and head and neck cancer cell sensitivity to ionizing radiation. Int J Oncol 41:1531-1540.
6. Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, Thomas SJ. 2006. Human papillomavirus and head and neck cancer: A systematic review and meta-analysis. Clin Otolaryngol 31:259-266.
7. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 2011. Global cancer statistics. Ca-Cancer J Clin 61:69-90.
8. Leemans CR, Braakhuis BJ, Brakenhoff RH. 2011. The molecular biology of head and neck cancer. Nat Rev Cancer 11:9-22.
9. Li W, Thompson CH, Xin D, Cossart YE, O'Brien CJ, McNeil EB, Gao K, Scolyer RA, Rose BR. 2003. Absence of human papillomavirus in tonsillar squamous cell carcinomas from Chinese patients. Am J Pathol 163:2185-2189.
10. Li X, Gao L, Li H, Gao J, Yang Y, Zhou F, Gao C, Li M, Jin Q. 2013. Human papillomavirus infection and laryngeal cancer risk: A systematic review and meta-analysis. J Infect Dis 207:479-488.
11. Liang C, Marsit CJ, McClean MD, Nelson HH, Christensen BC, Haddad RI, Clark JR, Wein RO, Grillone GA, Houseman EA, Halec G, Waterboer T, Pawlita M, Krane JF, Kelsey KT. 2012. Biomarkers of HPV in head and neck squamous cell carcinoma. Cancer Res 72:5004-5013.
12. Liu SS, Leung RC, Chan KK, Cheung AN, Ngan HY. 2010. Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay and comparison with the Roche Linear Array HPV genotyping assay. J Clin Microbiol 48:758-764.
13. Marur S, D'Souza G, Westra WH, Forastiere AA. 2010. HPV-associated head and neck cancer: A virus-related cancer epidemic. Lancet Oncol 11:781-789.
14. O'Rorke MA, Ellison MV, Murray LJ, Moran M, James J, Anderson LA. 2012. Human papillomavirus related head and neck cancer survival: A systematic review and meta-analysis. Oral Oncol 48:1191-1201.
15. Ragin CC, Taioli E. 2007. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta-analysis. Int J Cancer 121:1813-1820.
16. Ribeiro KB, Levi JE, Pawlita M, Koifman S, Matos E, Eluf-Neto J, Wunsch-Filho V, Curado MP, Shangina O, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Daudt A, Menezes A, Bencko V, Mates D, Fernandez L, Fabianova E, Gheit T, Tommasino M, Boffetta P, Brennan P, Waterboer T. 2011. Low human papillomavirus prevalence in head and neck cancer: Results from two large case-control studies in high-incidence regions. Int J Epidemiol 40:489-502.
17. Rischin D, Young RJ, Fisher R, Fox SB, Le QT, Peters LJ, Solomon B, Choi J, O'Sullivan B, Kenny LM, McArthur GA. 2009. Prognostic significance of HPV and p16 status in patients with oropharyngeal cancer treated on a large international phase III trial. 2009 ASCO annual meeting; Orlando, FL, USA; May 29-June2, 2009 Abstr 6004.
18. Saito Y, Yoshida M, Ushiku T, Omura G, Ebihara Y, Shimono T, Fukayama M, Yamasoba T, Asakage T. 2013. Prognostic value of p16 expression and alcohol consumption in Japanese patients with oropharyngeal squamous cell carcinoma. Cancer 119:2005-2011.
19. Schache AG, Liloglou T, Risk JM, Filia A, Jones TM, Sheard J, Woolgar JA, Helliwell TR, Triantafyllou A, Robinson M, Sloan P, Harvey-Woodworth C, Sisson D, Shaw RJ. 2011. Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: Sensitivity, specificity, and prognostic discrimination. Clin Cancer Res 17:6262-6271.
20. Siegel R, Naishadham D, Jemal A. 2012. Cancer statistics, 2012. Ca-Cancer J Clin 62:10-29.
21. Smeets SJ, Hesselink AT, Speel EJ, Haesevoets A, Snijders PJ, Pawlita M, Meijer CJ, Braakhuis BJ, Leemans CR, Brakenhoff RH. 2007. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 121:2465-2472.
22. Snow AN, Laudadio J. 2010. Human papillomavirus detection in head and neck squamous cell carcinomas. Adv Anat Pathol 17:394-403.
23. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, Shefler E, Ramos AH, Stojanov P, Carter SL, Voet D, Cortes ML, Auclair D, Berger MF, Saksena G, Guiducci C, Onofrio RC, Parkin M, Romkes M, Weissfeld JL, Seethala RR, Wang L, Rangel-Escareno C, Fernandez-Lopez JC, Hidalgo-Miranda A, Melendez-Zajgla J, Winckler W, Ardlie K, Gabriel SB, Meyerson M, Lander ES, Getz G, Golub TR, Garraway LA, Grandis JR. 2011. The mutational landscape of head and neck squamous cell carcinoma. Science 333:1157-1160.
24. Wei W, Shi Q, Guo F, Zhang BY, Chen C, Zhang NS, Dong XP. 2012. The distribution of human papillomavirus in tissues from patients with head and neck squamous cell carcinoma. Oncol Rep 28:1750-1756.